CoagulationDisorders near Valhalla, NY

Biography: Caitlin Gribbin, MD, is an Instructor in Medicine within the Division of Hematology and Oncology at Weill Cornell Medical Center. After earning her B.A. from Cornell University, Dr. Gribbin received her Medical Degree as well as Masters in Science from Weill Cornell Medical College. She completed her Internship and Residency as well as subsequent Fellowship training in Hematology and Oncology within the Medical Research Track at Weill Cornell Medicine/NewYork-Presbyterian Hospital. As a faculty member at Weill Cornell, Dr. Gribbin specializes in treating patients with lymphoma using cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. She is simultaneously focused on leading clinical and translational research studies aimed at improving lymphoma treatments by bringing novel scientific discoveries to patients. Dr. Gribbin has co-authored numerous publications and presentations at national and international meetings and has received several research grants, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award, and the Burroughs Wellcome Fund Award.

Biography: Dr. Evelyn Cantillo completed her undergraduate studies at Cornell University prior to pursuing a Master of Public Health degree at Columbia University. She subsequently earned a medical degree at the Albert Einstein College of Medicine, graduating with special distinction in Obstetrics and Gynecology. Her residency training in Obstetrics and Gynecology was completed at Tulane University, followed by a fellowship in Gynecologic Oncology and Breast Disease at the Women & Infants Hospital/Brown University.Dr. Cantillo's practice encompasses the surgical and medical management of the broad spectrum of gynecologic malignancies including uterine, ovary, cervix, vulva, and vagina. She is extensively trained in minimally invasive surgical techniques using traditional laparoscopy, as well as robotic platforms, for gynecologic cancer and complex benign conditions.Dr. Cantillo believes that every woman with gynecologic cancer should have access to the full complement of care. With this in mind, her aim is to expand access to clinical trials should this become necessary. She is a member of the New Investigators Committee of the national NRG (formerly Gynecologic Oncology Group/GOG). It's important to her that all populations be afforded the same opportunities and treatment.Her interests also include medical education. She has received numerous teaching and surgical awards during residency and fellowship training and has presented her research at regional and national conferences.

Biography: Dr. Laura S. Munoz Arcos is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.Dr. Munoz Arcos earned her medical degree from Universidad del Valle in Colombia, her home country. She then completed an internal medicine residency at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx, NY, followed by a Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital, where she served as Chief Fellow in her final year. During her fellowship, Dr. Munoz Arcos gained extensive clinical experience in treating all types of breast cancer while conducting translational research on liquid biopsy in breast cancer at Dr. Massimo Cristofanilli's laboratory. Her research focuses on identifying predictors of response to therapy in hormone receptor-sensitive metastatic breast cancer. In recognition of her work, she received the 2023 Conquer Cancer American Society of Clinical Oncology (ASCO) Young Investigator Award, a prestigious honor granted to only 100 recipients annually. Following the completion of her fellowship, Dr. Munoz Arcos joined the Division of Hematology and Medical Oncology as a faculty member, where she is focused on the treatment of breast cancer.

Biography: Dr. Bobak Parang completed his undergraduate studies at the University of Pennsylvania, where he majored in Biology. He subsequently earned his MD and PhD from Vanderbilt University School of Medicine. He then joined the Weill Cornell Medicine Physician Scientist Training Program where he completed his internal medicine residency and hematology / medical oncology fellowship. During his last year of fellowship, Dr. Parang served as Chief Fellow. As a member of the Weill Cornell Medicine faculty, Dr. Parang is a physician-scientist whose clinical and research interests are focused on lung cancer drug resistance and metastases.